Zitvogel, Laurence

Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy

Elkrief, A., Méndez-Salazar, E. O., Maillou, J., Vanderbilt, C. M., Gogia, P., Desilets, A., Messaoudene, M., Kelly, D., Ladanyi, M., Hellmann, M. D., et al. (2024) · npj Precision Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment

Cited by 68

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

Chen, J., Levy, A., Tian, A.-L., Huang, X., Cai, G., Fidelle, M., Rauber, C., Ly, P., Pizzato, E., Sitterle, L., et al. (2025) · Cancer Cell

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 67

Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

Goubet, A.-G., Wheeler, R., Fluckiger, A., Qu, B., Lemaître, F., Iribarren, K., Mondragón, L., Tidjani Alou, M., Pizzato, E., Durand, S., et al. (2021) · Cell Death & Differentiation

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 54

Microbiota Modulation of Myeloid Cells in Cancer Therapy

Goldszmid, R. S., Dzutsev, A., Viaud, S., Zitvogel, L., Restifo, N. P., & Trinchieri, G. (2015) · Cancer Immunology Research

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 46

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma

Paillet, J., Plantureux, C., Lévesque, S., Le Naour, J., Stoll, G., Sauvat, A., Caudana, P., Tosello Boari, J., Bloy, N., Lachkar, S., et al. (2021) · Journal of Experimental Medicine

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 41

Cross-reactivity between microbial and tumor antigens

Zitvogel, L., & Kroemer, G. (2022) · Current Opinion in Immunology

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 40

Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer

Montégut, L., de Cabo, R., Zitvogel, L., & Kroemer, G. (2022) · Cancer Discovery

Dietary Effects on HealthNutritional Studies and Diet

Cited by 38

Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality

Guillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 36

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

Alves Costa Silva, C., Piccinno, G., Suissa, D., Bourgin, M., Schreibelt, G., Durand, S., Birebent, R., Fidelle, M., Sow, C., Aprahamian, F., et al. (2024) · Nature Communications

Gut microbiota and healthCutaneous Melanoma Detection and Management

Cited by 33

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

Castoldi, F., Vacchelli, E., Zitvogel, L., Maiuri, M. C., Pietrocola, F., & Kroemer, G. (2019) · OncoImmunology

Autophagy in Disease and TherapyImmunotherapy and Immune Responses

Cited by 33

Immunosuppressive Cell Death in Cancer

Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology

Cell death mechanisms and regulationImmunotherapy and Immune Responses

Cited by 26

Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

Picard, M., Yonekura, S., Slowicka, K., Petta, I., Rauber, C., Routy, B., Richard, C., Iebba, V., Tidjani Alou, M., Becharef, S., et al. (2021) · Cell Death & Differentiation

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 24

Impact of the ONCOBIOME network in cancer microbiome research

Zitvogel, L., Derosa, L., Routy, B., Loibl, S., Heinzerling, L., de Vries, I. J. M., Engstrand, L., ONCOBIOME Network, Silva, C. A. C., Barbieri, D., et al. (2025) · Nature Medicine

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 23

Gut Microbiota–Related Biomarkers in Immuno-Oncology

Silva, C. A. C., Fidelle, M., Almonte, A. A., Derosa, L., & Zitvogel, L. (2025) · Annual Review of Pharmacology and Toxicology

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 22

Immunologic Correlates in the Course of Treatment With Immunomodulating Antibodies

Weide, B., Di Giacomo, A. M., Fonsatti, E., & Zitvogel, L. (2015) · Seminars in Oncology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 21

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

Birebent, R., Drubay, D., Alves Costa Silva, C., Marmorino, F., Vitali, G., Piccinno, G., Hurtado, Y., Bonato, A., Belluomini, L., Messaoudene, M., et al. (2025) · OncoImmunology

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 21

Microbiota-centered interventions to boost immune checkpoint blockade therapies

Almonte, A. A., Thomas, S., & Zitvogel, L. (2025) · Journal of Experimental Medicine

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 19

Benzodiazepines compromise the outcome of cancer immunotherapy

Montégut, L., Derosa, L., Messaoudene, M., Chen, H., Lambertucci, F., Routy, B., Zitvogel, L., Martins, I., & Kroemer, G. (2024) · OncoImmunology

Cancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune Response

Cited by 18

From mucosal infection to successful cancer immunotherapy

Goubet, A.-G., Rouanne, M., Derosa, L., Kroemer, G., & Zitvogel, L. (2023) · Nature Reviews Urology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 11

Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillance

Fidelle, M., Tian, A.-L., Zitvogel, L., & Kroemer, G. (2023) · OncoImmunology

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 10

Antibiotics impair immunotherapy for urothelial cancer

Derosa, L., & Zitvogel, L. (2020) · Nature Reviews Urology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 9

Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer

Montégut, L., Rousseau, A., Ungolo, C., Derosa, L., Fidelle, M., Alves Costa Silva, C., Routy, B., Zitvogel, L., Besse, B., Pasolli, E., et al. (2025) · OncoImmunology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 8

Impact of microbiota specific circulating memory T cells in response to immunotherapy.

Gattazzo, F., Birebent, R., Lebhar, I., Xiberras, M., Marques, M., Reni, A., Flament, C., Bonato, A., Belluomini, L., Chanfreau-Paris, H., et al. (2024) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 4

Gut-associated checkpoint as a prognostic biomarker in metastatic renal cell carcinoma (mRCC): Results from a randomized first-line clinical trial.

Saliby, R. M., Machaalani, M., Zhong, C., Alves Costa Silva, C., Labaki, C., Saad, E., Steiner, C., Yekeduz, E., Eid, M., Daoud Khatoun, W., et al. (2025) · Journal of Clinical Oncology

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 2